Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection

Year of publication

2012

Authors

Alsio, A.; Jannesson, A.; Langeland, N.; Pedersen, C.; Färkkilä, Martti Antero; Buhl, M. R.; Morch, K.; Westin, J.; Hellstrand, K.; Norkrans, G.; Lagging, M.; ,

Organizations and authors

Helsinki University Hospital

Färkkilä Martti Antero

University of Helsinki

Färkkilä Martti Antero

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

European journal of clinical microbiology and infectious diseases

Parent publication name

European Journal of Clinical Microbiology & Infectious Diseases

Volume

Issue

Pages

1631-1635

ISSN

0934-9723

Publication forum

55691

Open access

Open access in the publisher’s service

No information

Self-archived

Unknown

Other information

Fields of science

General medicine, internal medicine and other clinical medicine

Publication country

Germany

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company